|
| |
| KLSE: NOVAMSC (0026) | NOVA MSC BHD | ACE : Technology |
| Last Price | Today's Change | Day's Range | Trading Volume |
| 0.05 |  +0.005 (11.11%) | 0.045 - 0.05 | 2,823,300 |
| Trade this stock with 3 x trading limit. Find out more. |
Financials
Market Cap: 38 Million
| Latest Audited Result: 31-Mar-2019
| Latest Quarter: 30-Sep-2019 [#2]
| ||||||||||||||||||||||||||||||||||||||||||||||||||
Annual (Unaudited) ( EPS: 1.12, P/E: 4.56 )
| T4Q Result ( EPS: 0.08, P/E: 63.26 )
| Annualized Result ( EPS: 0.54, P/E: 9.12 )
|
Business Performance
Business Performance (By Quarter)
| Trailing 4 Quarters | Trailing 8 Quarters | |||
|---|---|---|---|---|
| Available Quarters | 4 Quarters | 8 Quarters | ||
| Continuous Quarters Of Revenue Growth | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
| Total Positive Profit Years | 3 / 4 | 75.00% | 6 / 8 | 75.00% |
| Continuous Quarters Of Positive Profit | 2 / 4 | 50.00% | 2 / 8 | 25.00% |
| Continuous Quarters Of Profit Growth | 2 / 4 | 50.00% | 2 / 8 | 25.00% |
| Continuous Quarters Of Adjusted EPS Growth | 2 / 4 | 50.00% | 2 / 8 | 25.00% |
| Total Dividend Years | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
| Continuous Quarters Of Dividend | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
| Continuous Quarters Of Dividend Growth | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
| Continuous Quarters Of Adjusted Dps Growth | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
| Average ROE | 0.09% | 1.22% | ||
| Average Net Profit Margin | -0.60% | -3.17% | ||
Business Performance (By Year)
| Last 5 Financial Years | Last 10 Financial Years | |||
|---|---|---|---|---|
| Available Years | 5 Years | 10 Years | ||
| Continuous Years Of Revenue Growth | 0 / 5 | 0.00% | 0 / 10 | 0.00% |
| Total Positive Profit Years | 3 / 5 | 60.00% | 5 / 10 | 50.00% |
| Continuous Years Of Positive Profit | 1 / 5 | 20.00% | 1 / 10 | 10.00% |
| Continuous Years Of Profit Growth | 2 / 5 | 40.00% | 2 / 10 | 20.00% |
| Continuous Years Of Adjusted EPS Growth | 2 / 5 | 40.00% | 2 / 10 | 20.00% |
| Total Dividend Years | 0 / 5 | 0.00% | 0 / 10 | 0.00% |
| Continuous Years Of Dividend | 0 / 5 | 0.00% | 0 / 10 | 0.00% |
| Continuous Years Of Dividend Growth | 0 / 5 | 0.00% | 0 / 10 | 0.00% |
| Continuous Years Of Adjusted Dps Growth | 0 / 5 | 0.00% | 0 / 10 | 0.00% |
| Average ROE | -7.22% | -7.39% | ||
| Average Net Profit Margin | -2.33% | -3.35% | ||
Key Result
Key Result
| T4Q | Annualized | Annual (Unaudited) | Last 10 FY Average | Last 5 FY Average | |
|---|---|---|---|---|---|
| Revenue | 51,589 | 45,612 | 53,019 | 42,812 | 57,213 |
| NP to SH | 594 | 4,120 | 8,235 | -1,480 | -1,871 |
| Dividend | 0 | - | - | - | - |
| Adjusted EPS | 0.08 | 0.54 | 1.12 | -0.19 | -0.24 |
| Adjusted DPS | 0.00 | 0.00 | 0.00 | - | - |
NP to SH = Net Profit Attributable to Shareholder, EPS = Earning Per Share, DPS = Dividend Per Share
All figures in '000 unless specified.
EPS & DPS's figures in Cent.
Growth
Growth (By Quarter)
| LQ QoQ | LQ YoY | CQ YoY | LQ vs Average of T4Q | LQ vs Average of T8Q | |
|---|---|---|---|---|---|
| Revenue | -24.39% | -13.73% | -5.90% | -23.87% | -27.83% |
| NP to Owner | 46.29% | -84.78% | -78.76% | 723.57% | 55.47% |
| Dividend | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Adj. EPS | 45.45% | -85.05% | -80.00% | 814.29% | 54.37% |
| Adj. DPS | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
LQ = Latest Quarter, CQ = Cumulative Quarter, T4Q = Trailing 4 Quarters, T8Q = Trailing 8 Quarters, QoQ = Quarter on Quarter, YoY = Year on Year
Growth (By Year)
| T4Q vs LFY | T4Q vs AL5FY | T4Q vs AL10FY | AQR vs LFY | AQR vs AL5FY | AQR vs AL10FY | LFY YoY | LFY vs AL5FY | LFY vs AL10FY | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | -2.70% | -9.83% | 20.50% | -13.97% | -20.28% | 6.54% | -27.35% | -7.33% | 23.84% |
| NP to Owner | -92.79% | 131.75% | 140.12% | -49.97% | 320.20% | 378.30% | 413.83% | 540.14% | 656.27% |
| Dividend | 0.00% | 0.00% | 0.00% | - % | - % | - % | 0.00% | 0.00% | 0.00% |
| Adj. EPS | -92.86% | 132.77% | 141.12% | -51.79% | 321.23% | 377.57% | 420.79% | 558.85% | 675.70% |
| Adj. DPS | 0.00% | 0.00% | 0.00% | - % | - % | - % | 0.00% | 0.00% | 0.00% |
T4Q = Trailing 4 Quarters, T8Q = Trailing 8 Quarters, AL5FY = Average of Last 5 Financial Years, AL10FY = Average of Last 10 Financial Years, LFY = Latest Financial Year AQR = Annualized Quarter Result, YoY = Year on Year
 KAQ4468 amacam ???? nikmat tak Basta 15 ??? hingga menjilat batu nisan ....kah kah kah 12/12/2019 9:42 PM Redplanet Regulatory Body Approves Marketing of SELENA That Can Detect 3 Eye Diseases 01.10.2019 Oct 2019 – It is with great pleasure to announce EyRIS’s first medical device after Heath Science Authority of Singapore (HSA) gave us the official approval. Our patented medical device, SELENA , is an effective assistive tool in the diagnosis of 3 eye diseases, diabetic retinopathy (DR), Glaucoma and Age-Related Macular Degeneration (AMD). Health Science Authority This approval closely follows the ISO13485:2016 certification we received for our Quality Management System (QMS) where we had to demonstrate our ability to provide medical devices and related services that consistently meet customer and HSA regulatory requirements. There are more than 415 million diabetics in the world today who require an annual eye check-up to prevent vision loss. Statistically, 3 in 10 diabetics suffer from diabetes induced eye disease and 1 in 10 develops blindness when left untreated. In South-East Asia alone, there are near 100 million persons who suffer from diabetes, more than 10% of the population. A World Health Organization report in 2017 highlighted a recent dramatic increase in diabetes and critically, “half of those cases remain undiagnosed, underscoring the need for rapid, low-cost solutions to reach the region’s underserved areas”. With the approval, we aim to assist stakeholders develop their screening programs 13/12/2019 10:04 PM  Miz Raya Bloom ku baru senam ikut video footloose sini https://whims2016.wordpress.com/ sekarang ku nak tengok tv pula 13/12/2019 10:07 PM Redplanet HEALTHCARE In healthcare, a new system dubbed Selena will be deployed across Singapore by 2022 to help detect eye conditions, including diabetic eye disease. 13/12/2019 11:02 PM Redplanet https://www.snec.com.sg/news/academic-medicine/singapores-artificial-intelligence-strategy-applying-ai-to-help-not-replace-people 13/12/2019 11:03 PM Miz Raya Bloom pada ku kaunter ini ok je, something got to do with health, good for long term, aging population pun makin meningkat, so ada keperluan....issue tak buat profit adalah perkara biasa dalam product softwares, sebab nak buat sebijik pun telan banyak belanja, so nak cepat untung, kena market, market and market the products sampai jadi macam revenue, kalau tak sanggup tunggu boleh je lari kikiki 14/12/2019 9:02 AM Miz Raya Bloom Xkenal pon. Pada ku you stay or you leave personal choice. Nobody paksa you. Kalau ku unhappy, ku cari tempat lain yang boleh buat ku happy. Hari2 cakap unhappy pun tak jadi apa pon 14/12/2019 2:43 PM DickyMe "DickyMe "Posted by KAQ4468 > Jul 22, 2015 9:25 AM | Report Abuse DC ....kita punya Ms. Nova cantekkkk punya ....itu 0.160 punya bau sudah ada woooo...tarak apa ,kasi dia jalan cara dia ....sekali henjut kabommmm 20 cents sekali lepak ..." Bau kapla butuh adalah..kikikiki. 02/07/2019 9:38 PM DickyMe 5 sen coming <<<< 17/04/2019 9:44 PM" <<<< =========================== Ramalan hampir dicapai, tinggal setengah sen saja. Di mana ada Dreamxxxxx, pasti kaunter tu jahanam. Kikikiki. 15/12/2019 2:32 PM Jordan_Tulid the annoying Zjay is Ku Miss Bunga Raya? ...why I always bising-bising...thi$ counter I top-up till RM100k ..that RM100K Now become ~RM25k.. 15/12/2019 10:03 PM zakiazre4 Dont blame him/her. Someone else at fault and still doesnt want to admit. 15/12/2019 10:31 PM yhwong just saw the proposal been approved by Bursa dy. so when will be the exercise date ya ? 17/12/2019 2:40 PM Twowah123 Way to go 0.04-0.05. As mention will wondering in this price till ri completed n see the trend then. Any above 0.06 is opportunity to sell 19/12/2019 3:10 PM KAQ4468 amacam ???? nikmat tak Basta 15 ??? hingga menjilat batu nisan ....kah kah kah 26/12/2019 6:30 PM Jordan_Tulid Today just a trap.. always up one day.. day to come sure drop to 0.05..Thank You Mr Con LTA (Logic Trap Analysis). 02/01/2020 11:12 PM Twowah123 Still keeping my statement. Any above 0.06 is oppurtunity to sell. Till ri issuance price will wandering 0.04 - 0.05. 03/01/2020 9:45 AM zakiazre4 Ask LTA. For so long he keeps quite on this counter. Last time say huat huat this one. 17/01/2020 8:25 PM Rosen Stella http://www.nova-hub.com/novanews/land-transport-authority-singapore-awards-project-to-nova-for-era-system-upgrade/ potential gem price drop due to right issue only 21/01/2020 10:00 AM Karlocs Jan 2020 –Singapore’s Land Transport Authority (LTA) has awarded to novaCITYNETS the project to upgrade and enhance the web-based Enterprise Registry and Archival (ERA) System. 23/01/2020 12:02 AM sayyouloveme Dec, 2019. The Good Distribution Practices for Medical Devices (GDPMD) specifies the requirements for a quality management system to be established, implemented and maintained by an establishment in carrying out activities in medical device supply-chain. Nova MSC recently received its GDPMD certification from Medical Device, Authority of Malaysia upon completing an audit to confirm our compliance with Malaysian medical device regulatory requirements as stipulated in Medical Device Act. This paves the way for SELENA+ to be deployed in Malaysia. Just wait for good news. They are in good track of ISO certification before marketing to the world. 22/02/2020 4:53 PM AlfI3 Still got few days for d RI to commence, but no prc n volume movemn during past weeks; excep last Fri ony saw some movemns. Wat a pity counter 23/02/2020 7:32 AM  |
|